CVE:MED Medgold Resources (MED) Stock Price, News & Analysis → Are you prepared for a financial lockdown? (From Weiss Ratings) (Ad) Free MED Stock Alerts C$0.0050 -0.01 (-50.00%) (As of 11/22/2022) Add Compare Share Share Today's RangeC$0.01▼C$0.0150-Day RangeC$0.01▼C$0.0152-Week RangeC$0.01▼C$0.03Volume4,800 shsAverage Volume131,112 shsMarket CapitalizationC$673,950.00P/E RatioN/ADividend Yield38,400.00%Price TargetN/A Stock AnalysisStock Analysis Get Medgold Resources alerts: Email Address Ad Weiss RatingsMassive Crisis Looming — Protect Your Savings NowToday, Dr. Weiss is coming forward with a new warning, Only this time, it's not about the stock market, inflation, or recession … This time, it's about your financial freedom.Click here to learn how to prepare before it's too late. About Medgold ResourcesMedgold Resources Corp., an exploration stage company, engages in the acquisition and exploration of precious metal properties in Europe. The company explores for gold, silver, copper, lead, and zinc deposits. It holds a 100% interest in the Tlamino project comprising three exploration licenses, such as Donje Tlamino and Surlica-Dukat covering an area of 192 square kilometers located in the far southeast of Serbia. The company was incorporated in 1966 and is headquartered in Vancouver, Canada.Read More MED Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MED Stock News HeadlinesJune 2, 2022 | investing.comMedgold Resources Corp (MED)See More Headlines Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medgold Resources and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorBasic Materials Industry Other Precious Metals & Mining Sub-IndustryN/A Current SymbolCVE:MED CUSIPN/A CIKN/A Webwww.medgoldresources.com Phone+1-604-8015432FaxN/AEmployees713Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on Equity-4,352.78% Return on Assets-116.22% Debt Debt-to-Equity RatioN/A Current Ratio0.09 Quick Ratio0.59 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares134,790,000Free FloatN/AMarket CapC$673,950.00 OptionableNot Optionable Beta0.61 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Jeremy CrozierPresident, CEO & DirectorMr. Kevin Bales (Age 57)Chief Financial Officer Comp: $29.25kMr. Brett A. Kagetsu B.Comm (Age 54)Esq., LLB, Corporate Secretary Mr. Brent Cook BSc (Geology)Technical AdvisorKey CompetitorsEastfield ResourcesCVE:ETFTres-Or ResourcesCVE:TRSMexican Gold MiningCVE:MEXPacific Bay MineralsCVE:PBMMammoth ResourcesCVE:MTHView All Competitors MED Stock Analysis - Frequently Asked Questions How have MED shares performed in 2024? Medgold Resources' stock was trading at C$0.01 at the beginning of 2024. Since then, MED shares have increased by 0.0% and is now trading at C$0.01. View the best growth stocks for 2024 here. Is Medgold Resources a good dividend stock? Medgold Resources (CVE:MED) pays an annual dividend of C$1.92 per share and currently has a dividend yield of 14.04%. MED has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. What other stocks do shareholders of Medgold Resources own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medgold Resources investors own include Nevsun Resources (NSU) and How do I buy shares of Medgold Resources? Shares of MED stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:MED) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | Sponsored"Trump Loophole" Beats InflationThe demise of the "petrodollar" appears imminent. And the implications for Americans could be dire.Colonial Metals | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medgold Resources Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medgold Resources With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.